Literature DB >> 14657390

A glycopeptide in complex with MHC class I uses the GalNAc residue as an anchor.

Vasso Apostolopoulos1, Elizabeth Yuriev, Paul A Ramsland, Jodie Halton, Carla Osinski, Wenjun Li, Magdalena Plebanski, Hans Paulsen, Ian F C McKenzie.   

Abstract

Peptides bind MHC class I molecules by anchoring hydrophobic side chains into pockets in the peptide binding groove. Here, we report an immunogenic (in vitro and in vivo) MUC1 glycopeptide (MUC1-8-5GalNAc) bound to H-2Kb, fully crossreactive with the nonglycosylated variant. Molecular modeling showed that the central P5-Thr-GalNAc residue points into the C pocket and forms van der Waals and hydrogen bond interactions with the MHC class I. As predicted, GalNAc, a modified peptide carrying an additional anchor in the central C anchor pocket, increased the affinity by approximately 100-fold compared with the native low-affinity peptide (MUC1-8). The findings demonstrate that glycopeptides associated with MHC class I molecules can use GalNAc to anchor the peptide in the groove and enable high-affinity binding.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14657390      PMCID: PMC299892          DOI: 10.1073/pnas.2432220100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  Crystal structures of two viral peptides in complex with murine MHC class I H-2Kb.

Authors:  D H Fremont; M Matsumura; E A Stura; P A Peterson; I A Wilson
Journal:  Science       Date:  1992-08-14       Impact factor: 47.728

2.  In vitro peptide binding to soluble empty class I major histocompatibility complex molecules isolated from transfected Drosophila melanogaster cells.

Authors:  M Matsumura; Y Saito; M R Jackson; E S Song; P A Peterson
Journal:  J Biol Chem       Date:  1992-11-25       Impact factor: 5.157

3.  HLA-B27 binding peptides derived from the 57 kD heat shock protein of Chlamydia trachomatis: novel insights into the peptide binding rules.

Authors:  A Daser; H Urlaub; P Henklein
Journal:  Mol Immunol       Date:  1994-04       Impact factor: 4.407

4.  Parameters for using mannan-MUC1 fusion protein to induce cellular immunity.

Authors:  G A Pietersz; W Li; V Popovski; J A Caruana; V Apostolopoulos; I F McKenzie
Journal:  Cancer Immunol Immunother       Date:  1998-02       Impact factor: 6.968

5.  Induction of HLA-A2-restricted CTLs to the mucin 1 human breast cancer antigen.

Authors:  V Apostolopoulos; V Karanikas; J S Haurum; I F McKenzie
Journal:  J Immunol       Date:  1997-12-01       Impact factor: 5.422

6.  The structural basis of MHC control of collagen-induced arthritis; binding of the immunodominant type II collagen 256-270 glycopeptide to H-2Aq and H-2Ap molecules.

Authors:  P Kjellén; U Brunsberg; J Broddefalk; B Hansen; M Vestberg; I Ivarsson; A Engström; A Svejgaard; J Kihlberg; L Fugger; R Holmdahl
Journal:  Eur J Immunol       Date:  1998-02       Impact factor: 5.532

7.  Glycopeptides bind MHC molecules and elicit specific T cell responses.

Authors:  C V Harding; J Kihlberg; M Elofsson; G Magnusson; E R Unanue
Journal:  J Immunol       Date:  1993-09-01       Impact factor: 5.422

8.  Cell-mediated immune responses to MUC1 fusion protein coupled to mannan.

Authors:  V Apostolopoulos; G A Pietersz; I F McKenzie
Journal:  Vaccine       Date:  1996-06       Impact factor: 3.641

9.  Crystallization of murine major histocompatibility complex class I H-2Kb with single peptides.

Authors:  E A Stura; M Matsumura; D H Fremont; Y Saito; P A Peterson; I A Wilson
Journal:  J Mol Biol       Date:  1992-12-05       Impact factor: 5.469

10.  Recognition of carbohydrate by major histocompatibility complex class I-restricted, glycopeptide-specific cytotoxic T lymphocytes.

Authors:  J S Haurum; G Arsequell; A C Lellouch; S Y Wong; R A Dwek; A J McMichael; T Elliott
Journal:  J Exp Med       Date:  1994-08-01       Impact factor: 14.307

View more
  29 in total

1.  A Tn antigen binding lectin from Myrsine coriacea displays toxicity in human cancer cell lines.

Authors:  Andrea Medeiros; Nora Berois; Marcelo Incerti; Sylvie Bay; Laura Franco Fraguas; Eduardo Osinaga
Journal:  J Nat Med       Date:  2012-05-30       Impact factor: 2.343

2.  Penetratin tandemly linked to a CTL peptide induces anti-tumour T-cell responses via a cross-presentation pathway.

Authors:  Dodie S Pouniotis; Vasso Apostolopoulos; Geoffrey A Pietersz
Journal:  Immunology       Date:  2006-03       Impact factor: 7.397

3.  Identification of O-glycosylated decapeptides within the MUC1 repeat domain as potential MHC class I (A2) binding epitopes.

Authors:  Tanja Ninkovic; Leo Kinarsky; Katja Engelmann; Vladimir Pisarev; Simon Sherman; Olivera J Finn; Franz-Georg Hanisch
Journal:  Mol Immunol       Date:  2008-11-12       Impact factor: 4.407

4.  O-glycosylated versus non-glycosylated MUC1-derived peptides as potential targets for cytotoxic immunotherapy of carcinoma.

Authors:  D Stepensky; E Tzehoval; E Vadai; L Eisenbach
Journal:  Clin Exp Immunol       Date:  2006-01       Impact factor: 4.330

5.  Enhanced major histocompatibility complex class I binding and immune responses through anchor modification of the non-canonical tumour-associated mucin 1-8 peptide.

Authors:  Eliada Lazoura; Jodie Lodding; William Farrugia; Paul A Ramsland; James Stevens; Ian A Wilson; Geoffrey A Pietersz; Vasso Apostolopoulos
Journal:  Immunology       Date:  2006-11       Impact factor: 7.397

Review 6.  The tumour glyco-code as a novel immune checkpoint for immunotherapy.

Authors:  Ernesto RodrÍguez; Sjoerd T T Schetters; Yvette van Kooyk
Journal:  Nat Rev Immunol       Date:  2018-02-05       Impact factor: 53.106

7.  N-Glycosylation of Seasonal Influenza Vaccine Hemagglutinins: Implication for Potency Testing and Immune Processing.

Authors:  Yanming An; Lisa M Parsons; Ewa Jankowska; Darya Melnyk; Manju Joshi; John F Cipollo
Journal:  J Virol       Date:  2019-01-04       Impact factor: 5.103

8.  Altered peptide ligands of myelin basic protein ( MBP87-99 ) conjugated to reduced mannan modulate immune responses in mice.

Authors:  Maria Katsara; Elizabeth Yuriev; Paul A Ramsland; Theodore Tselios; George Deraos; Athanasios Lourbopoulos; Nikolaos Grigoriadis; John Matsoukas; Vasso Apostolopoulos
Journal:  Immunology       Date:  2009-12       Impact factor: 7.397

9.  Adaptive immune activation: glycosylation does matter.

Authors:  Margreet A Wolfert; Geert-Jan Boons
Journal:  Nat Chem Biol       Date:  2013-12       Impact factor: 15.040

10.  Synthesis of a Liposomal MUC1 Glycopeptide-Based Immunotherapeutic and Evaluation of the Effect of l-Rhamnose Targeting on Cellular Immune Responses.

Authors:  Partha Karmakar; Kyunghee Lee; Sourav Sarkar; Katherine A Wall; Steven J Sucheck
Journal:  Bioconjug Chem       Date:  2015-12-09       Impact factor: 4.774

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.